CX3CR1及小胶质细胞在视网膜退行性疾病中的研究进展
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

基金项目:

国家自然科学基金面上项目(No.81774371)


Research advances of chemokine receptor CX3CR1 and microglia in retinal degenerative diseases
Author:
Affiliation:

Fund Project:

National Natural Science Foundation of China(No.81774371)

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    视网膜退行性疾病如视网膜色素变性、年龄相关性黄斑变性等是临床主要一类致盲性眼病,病因复杂并对视力造成不可逆性损伤。CX3CR1是趋化因子CX3CL1的特异性受体,二者通过对机体免疫系统的调控参与全身各项生理功能及病理变化。近年来研究指出CX3CR1调节视网膜小胶质细胞的活性及功能,二者在视网膜退行性疾病过程中发挥重要作用。本文就趋化因子受体CX3CR1的结构功能及其与小胶质细胞在视网膜退行性疾病中的作用研究进行综述,为今后此类疾病研究及治疗提供思路及方向。

    Abstract:

    Retinal degenerative diseases such as retinitis pigmentosa and age-related macular degeneration are the main clinical blinding eye diseases with complex etiology and irreversible damage to vision. CX3CR1 is a specific receptor of the chemokine CX3CL1. Both of them participate in various physiological functions and pathological changes of the whole body through regulating the immune system of the body. In recent years, studies have pointed out that CX3CR1 regulates the activity and function of retinal microglia, which play an important role in the process of retinal degenerative diseases. In this paper, the structure and function of the chemokine receptor CX3CR1 and the role of microglia in retinal degenerative diseases were reviewed, so as to provide ideas and directions for future research and treatment of such diseases.

    参考文献
    相似文献
    引证文献
引用本文

祁玉麟,贾茜钰,叶河江. CX3CR1及小胶质细胞在视网膜退行性疾病中的研究进展.国际眼科杂志, 2021,21(8):1363-1367.

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2020-09-27
  • 最后修改日期:2021-07-02
  • 录用日期:
  • 在线发布日期: 2021-07-21
  • 出版日期: